---
title: "4528.JP (4528.JP) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/4528.JP/news.md"
symbol: "4528.JP"
name: "4528.JP"
parent: "https://longbridge.com/en/quote/4528.JP.md"
datetime: "2026-05-21T23:18:38.006Z"
locales:
  - [en](https://longbridge.com/en/quote/4528.JP/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/4528.JP/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/4528.JP/news.md)
---

# 4528.JP (4528.JP) — Related News

### [Analyst Estimates: Here's What Brokers Think Of Ono Pharmaceutical Co., Ltd. (TSE:4528) After Its Yearly Report](https://longbridge.com/en/news/286163822.md)
*2026-05-12T22:01:14.000Z*
> Ono Pharmaceutical Co., Ltd. (TSE:4528) shares rose 7.1% to JP¥2,479 after its yearly report, with revenues of JP¥516b m

### [Ono Pharmaceutical (TSE:4528) Earnings Growth Versus Forecast Declines Tests Bull And Bear Narratives](https://longbridge.com/en/news/285822299.md)
*2026-05-09T22:04:09.000Z*
> Ono Pharmaceutical (TSE:4528) reported FY 2026 Q4 revenue of ¥118.7 billion and EPS of ¥1.74, achieving 39.4% earnings g

### [ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso](https://longbridge.com/en/news/279072314.md)
*2026-03-13T16:30:30.000Z*
> ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso

### [MHRA approves new treatment for severe alopecia areata](https://longbridge.com/en/news/278894000.md)
*2026-03-12T13:26:33.000Z*
> The MHRA has approved deuruxolitinib, branded as Leqselvi, for treating severe alopecia areata in adults. This new treat

### [Curatis and Neupharma sign development agreement for corticorelin in Japan](https://longbridge.com/en/news/278862080.md)
*2026-03-12T10:13:44.000Z*
> A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings.

### [Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference](https://longbridge.com/en/news/277860992.md)
*2026-03-05T01:43:12.000Z*
> AnnJi Pharmaceutical Co., Ltd. participated in the 2026 KDA Conference, presenting advancements in AJ201, a potential fi